How Serum and Bharat battled for COVID-19 vaccine

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it.One senior person, who was very familiar with the sector, told me, 'The message has......

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's......